Interventional Cardiology Devices Market
PUBLISHED: 2023 ID: SMRC22915
SHARE
SHARE

Interventional Cardiology Devices Market

Interventional Cardiology Devices Market Forecasts to 2028 - Global Analysis By Product (Structural Devices, Angioplasty Stents, Catheters, Hemodynamic Flow Alteration Devices, Angioplasty Ballons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Other Products), End User (Ambulatory Surgical Centers, Hospitals, Other End Users) and Geography

4.1 (54 reviews)
4.1 (54 reviews)
Published: 2023 ID: SMRC22915

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2020-2028

Estimated Year Value (2022)

US $17.5 BN

Projected Year Value (2028)

US $30.4 BN

CAGR (2022 - 2028)

9.7%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Interventional Cardiology Devices Market is accounted for $17.5 billion in 2022 and is expected to reach $30.4 billion by 2028 growing at a CAGR of 9.7% during the forecast period. Specialised equipment is needed for interventional operations in order to treat restricted arteries, damaged or weakened vessels, or other impacted areas of the heart anatomy without the need for surgery. As a result, cardiac catheterization laboratories or hospitals utilise interventional cardiology tools including coronary stents, cutting balloon catheters, and percutaneous transluminal coronary angioplasty (PTCA) to undertake minimally invasive procedures.

According to the results published in the journal of Annals of Thoracic Surgery, 2020, approximately a 53% decrease in the total cardiac surgery volume was observed in the United States in 2020 relative to 2019, a major reason of which was the COVID-19 pandemic.



Market Dynamics:

Driver:

Rising tobacco consumption and increasing incidence of obesity

Cardiovascular disorders are distinctly correlated with smoking and obesity. Smoking makes blood vessels more likely to develop plaque. Smoke from cigarettes contains chemicals that make blood thicken and clot in veins and arteries. When the arteries that provide blood to the heart are constricted by plaque or clogged by clots, coronary heart disease develops. Because of this, smokers are considerably more likely than non-smokers to acquire CAD. Thus, it is anticipated that the demand for cardiovascular devices, especially interventional cardiology equipment, would rise in the coming years as a result of cigarette smoking and obesity.

Restraint:

Complications of Interventional Cardiology procedures

Blood clots forming around the stent are known as stent thrombosis. Restenosis: The return of stenosis (abnormal arterial narrowing) following corrective surgery, and as some of the stents are metallic, an MRI scan cannot be done. The complications listed above are linked to interventional cardiac procedures. The development of the worldwide market for interventional cardiology devices is anticipated to be hampered by complications related to interventional cardiology operations.

Opportunity:

Rising Number of Product Launches by Key Players

The leading players' increasing product introductions are projected to fuel the market for interventional cardiology devices. The significant prevalence of cardiovascular conditions including valvar defects and atrial stenosis in developing countries like China, India, and Brazil has resulted in a large need for interventional cardiology equipment for treatment. Major players are increasingly collaborating to carry out a number of clinical trials on interventional devices.

Threat:

Stringent and complex standards

The challenging regulatory requirements for medical device affiliation are changed to accommodate shifting consumer expectations. The legal ramifications of these restrictions make them challenging. To maintain public safety, performance and quality of medical devices must be closely inspected. Therefore, the complicated and strict criteria employed to approve medical equipment may restrict market expansion.

Covid-19 Impact

The market was significantly impacted by the COVID-19 epidemic. Worldwide elective surgical operations were greatly impacted by COVID-19, which also had a huge impact on the worldwide market. Treatments for structural and coronary heart disease were delayed while medical institutions battled an influx of individuals with COVID-19 infection.

The Drug Eluting Stents segment is expected to be the largest during the forecast period

The Drug Eluting Stents segment is estimated to have a lucrative growth. Drug-eluting stents are used to assist stop the development of scar tissue in the arterial lining by coating them with medicine that is gradually released. By keeping the artery smooth and wide open, this promotes healthy blood flow. These stents perform better than self-expanding & balloon-expanding stents and are typically utilised for the lower extremities. Therefore, it is anticipated that the acceptance of cutting-edge cardiovascular therapies and the development of drug-eluting stent technology would be the main factors driving the segment's growth. The drug-eluting stents sector is therefore anticipated to increase strongly throughout the projected period as a result of the aforementioned causes.

The Hospitals segment is expected to have the highest CAGR during the forecast period

The Hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period owing to the hospital operations have a high success rate. Less than 6% of people who have a cardiac arrest outside of a hospital survive, compared to over 200,000 cardiac arrests each year in hospitals where 24% of patients do.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising consumption of unhealthy foods in emerging nations, which is predicted to accelerate the expansion of the market for interventional cardiology devices. The administrations in the area are fervently striving to organise a plethora of initiatives, programmes, and campaigns to educate the populace about cardiovascular illnesses and their impact on life in order to address the problem.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to region's advanced healthcare infrastructure, supportive government product development initiatives, high patient awareness levels, and expanding target patient population. Because North America can support a high rate of medical device innovation and has a high rate of consumption of expensive interventional cardiology equipment, it dominates the market under investigation. A few significant market participants in the area are also creating innovative goods and technologies to compete with already available goods, while others are purchasing and collaborating with the other trending businesses in the industry.



Key players in the market

Some of the key players profiled in the Interventional Cardiology Devices Market include Philips, Merck KGAA, Thermo Fisher Scientific, Inc., Boston Scientific, Abbott, Medtronic, Edwards Lifesciences Corporation, Koninklijke Philips N.V., iVascular , Biosensors International Group , Cardinal Health and Terumo Corporation.

Key Developments:

In December 2022, Boston Scientific Corporation acquired a majority of share in Acotec Scientific Holdings. The acquisition will help Boston Scientific Corporation to expand its product portfolio and market in China.

In February 2021, iVascular announced the launch of new lengths for the Angiolite drug-eluting stent (DES) for the treatment of long lesions in the coronary arteries. The 44- and 49-mm lengths received the European CE Mark approval for the treatment of diffuse lesions.

Products Covered:
• Structural Devices
• Guidewires
• Angioplasty Stents
• Catheters
• Hemodynamic Flow Alteration Devices
• Angioplasty Ballons
• Plaque Modification Devices
• Inferior Vena Cava (IVC) Filters
• Accessories
• Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
• Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
• Other Devices
• Other Products

End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Interventional Cardiology Devices Market, By Product
5.1 Introduction
5.2 Structural Devices
5.2.1 Aortic Valve Therapy Devices
5.2.2 Other Therapy Devices
5.2.2.1 Tricuspid Vvalve
5.2.2.2 Left Atrial Appendage Therapy Devices
5.2.2.3 Pulmonary Valve
5.2.2.4 Mitral Valve
5.3 Guidewires
5.4 Angioplasty Stents
5.4.1 Bare Mental Stents
5.4.2 Drug Eluting Stents
5.4.3 Bioabsorbable Stents
5.5 Catheters
5.5.1 IVUS/OCT Catheters
5.5.2 Angiography Catheters
5.5.3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters
5.6 Hemodynamic Flow Alteration Devices
5.6.1 Chronic Total Occlusion Devices
5.6.2 Embolic Protection Devices
5.7 Angioplasty Ballons
5.7.1 Drug Eluting Ballons
5.7.2 Old/ Normal Ballons
5.7.3 Cutting & Scorimg Ballons
5.8 Plaque Modification Devices
5.8.1 Thrombectomy Devices
5.8.2 Atherectomy Devices
5.9 Inferior Vena Cava (IVC) Filters
5.10 Accessories
5.11 Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
5.12 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
5.13 Other Devices
5.13.1 Ballon Inflation Devices
5.13.2 Vascular Closure Devices
5.13.3 Hemostasis Valves
5.13.4 Introducer Sheaths
5.14 Other Products

6 Global Interventional Cardiology Devices Market, By End User
6.1 Introduction
6.2 Ambulatory Surgical Centers
6.3 Hospitals
6.4 Other End Users

7 Global Interventional Cardiology Devices Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Philips
9.2 Merck KGAA
9.3 Thermo Fisher Scientific, Inc.
9.4 Boston Scientific
9.5 Abbott
9.6 Medtronic
9.7 Edwards Lifesciences Corporation
9.8 Koninklijke Philips N.V.
9.9 iVascular
9.10 Biosensors International Group
9.11 Cardinal Health
9.12 Terumo Corporation

List of Tables
1 Global Interventional Cardiology Devices Market Outlook, By Region (2020-2028) ($MN)
2 Global Interventional Cardiology Devices Market Outlook, By Product (2020-2028) ($MN)
3 Global Interventional Cardiology Devices Market Outlook, By Structural Devices (2020-2028) ($MN)
4 Global Interventional Cardiology Devices Market Outlook, By Aortic Valve Therapy Devices (2020-2028) ($MN)
5 Global Interventional Cardiology Devices Market Outlook, By Other Therapy Devices (2020-2028) ($MN)
6 Global Interventional Cardiology Devices Market Outlook, By Tricuspid Vvalve (2020-2028) ($MN)
7 Global Interventional Cardiology Devices Market Outlook, By Left Atrial Appendage Therapy Devices (2020-2028) ($MN)
8 Global Interventional Cardiology Devices Market Outlook, By Pulmonary Valve (2020-2028) ($MN)
9 Global Interventional Cardiology Devices Market Outlook, By Mitral Valve (2020-2028) ($MN)
10 Global Interventional Cardiology Devices Market Outlook, By Guidewires (2020-2028) ($MN)
11 Global Interventional Cardiology Devices Market Outlook, By Angioplasty Stents (2020-2028) ($MN)
12 Global Interventional Cardiology Devices Market Outlook, By Bare Mental Stents (2020-2028) ($MN)
13 Global Interventional Cardiology Devices Market Outlook, By Drug Eluting Stents (2020-2028) ($MN)
14 Global Interventional Cardiology Devices Market Outlook, By Bioabsorbable Stents (2020-2028) ($MN)
15 Global Interventional Cardiology Devices Market Outlook, By Catheters (2020-2028) ($MN)
16 Global Interventional Cardiology Devices Market Outlook, By IVUS/OCT Catheters (2020-2028) ($MN)
17 Global Interventional Cardiology Devices Market Outlook, By Angiography Catheters (2020-2028) ($MN)
18 Global Interventional Cardiology Devices Market Outlook, By Percutaneous Transluminal Coronary Angioplasty (PTCA) Guiding Catheters (2020-2028) ($MN)
19 Global Interventional Cardiology Devices Market Outlook, By Hemodynamic Flow Alteration Devices (2020-2028) ($MN)
20 Global Interventional Cardiology Devices Market Outlook, By Chronic Total Occlusion Devices (2020-2028) ($MN)
21 Global Interventional Cardiology Devices Market Outlook, By Embolic Protection Devices (2020-2028) ($MN)
22 Global Interventional Cardiology Devices Market Outlook, By Angioplasty Ballons (2020-2028) ($MN)
23 Global Interventional Cardiology Devices Market Outlook, By Drug Eluting Ballons (2020-2028) ($MN)
24 Global Interventional Cardiology Devices Market Outlook, By Old/ Normal Ballons (2020-2028) ($MN)
25 Global Interventional Cardiology Devices Market Outlook, By Cutting & Scorimg Ballons (2020-2028) ($MN)
26 Global Interventional Cardiology Devices Market Outlook, By Plaque Modification Devices (2020-2028) ($MN)
27 Global Interventional Cardiology Devices Market Outlook, By Thrombectomy Devices (2020-2028) ($MN)
28 Global Interventional Cardiology Devices Market Outlook, By Atherectomy Devices (2020-2028) ($MN)
29 Global Interventional Cardiology Devices Market Outlook, By Inferior Vena Cava (IVC) Filters (2020-2028) ($MN)
30 Global Interventional Cardiology Devices Market Outlook, By Accessories (2020-2028) ($MN)
31 Global Interventional Cardiology Devices Market Outlook, By Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires (2020-2028) ($MN)
32 Global Interventional Cardiology Devices Market Outlook, By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons (2020-2028) ($MN)
33 Global Interventional Cardiology Devices Market Outlook, By Other Devices (2020-2028) ($MN)
34 Global Interventional Cardiology Devices Market Outlook, By Ballon Inflation Devices (2020-2028) ($MN)
35 Global Interventional Cardiology Devices Market Outlook, By Vascular Closure Devices (2020-2028) ($MN)
36 Global Interventional Cardiology Devices Market Outlook, By Hemostasis Valves (2020-2028) ($MN)
37 Global Interventional Cardiology Devices Market Outlook, By Introducer Sheaths (2020-2028) ($MN)
38 Global Interventional Cardiology Devices Market Outlook, By Other Products (2020-2028) ($MN)
39 Global Interventional Cardiology Devices Market Outlook, By End User (2020-2028) ($MN)
40 Global Interventional Cardiology Devices Market Outlook, By Ambulatory Surgical Centers (2020-2028) ($MN)
41 Global Interventional Cardiology Devices Market Outlook, By Hospitals (2020-2028) ($MN)
42 Global Interventional Cardiology Devices Market Outlook, By Other End Users (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
 

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials